160 related articles for article (PubMed ID: 32016970)
1. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA.
Zhang G; Chen HX; Yang SN; Zhao J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):691-698. PubMed ID: 32016970
[TBL] [Abstract][Full Text] [Related]
2. Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis.
Bo W; Yu N; Wang X; Wang C; Liu C
Neoplasia; 2024 Feb; 48():100960. PubMed ID: 38184887
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p.
Chen T; Qin S; Gu Y; Pan H; Bian D
Mol Genet Genomic Med; 2019 Aug; 7(8):e757. PubMed ID: 31207175
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
[TBL] [Abstract][Full Text] [Related]
9. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
Ma XR; Xu YL; Qian J; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Jing H; Xia H; Qian M; Lv X
Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
[TBL] [Abstract][Full Text] [Related]
13. The Long Noncoding RNA MAGI1-IT1 Regulates the miR-302d-3p/IGF1 Axis to Control Gastric Cancer Cell Proliferation.
Wang Q; Gu M; Zhuang Y; Chen J
Cancer Manag Res; 2021; 13():2959-2967. PubMed ID: 33833579
[TBL] [Abstract][Full Text] [Related]
14. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
[TBL] [Abstract][Full Text] [Related]
16. CHML targeted by miR-199a-3p promotes non-small cell lung cancer cell growth via binding to Rab5A.
Dong C; Cao H; Liu Z; Xi L; Shi Y; Yang R
Pathol Res Pract; 2021 Nov; 227():153626. PubMed ID: 34649053
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
19. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
[TBL] [Abstract][Full Text] [Related]
20. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
Liao XH; Wang Y; Zhong B; Zhu SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
